An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).
Wang HY, Gong S, Li GH, Yao YZ, Zheng YS, Lu XH, Wei SH, Qin WW, Liu HB, Wang MC, Xi JY, Chen LM, Zhang M, Zhang XX, Zhang HY, Zhang CS, Wald DN, Zhu HH, Liu L, He PC.
Wang HY, et al.
Blood Cancer J. 2022 Nov 21;12(11):158. doi: 10.1038/s41408-022-00753-y.
Blood Cancer J. 2022.
PMID: 36404343
Free PMC article.
Clinical Trial.